Home  |  Contact

Cellosaurus LNCaP-Rf (CVCL_4792)

[Text version]

Cell line name LNCaP-Rf
Synonyms LNCaP-RF
Accession CVCL_4792
Resource Identification Initiative To cite this cell line use: LNCaP-Rf (RRID:CVCL_4792)
Comments Doubling time: 34.14 hours (https://www.synapse.org/#!Synapse:syn2347014).
Sequence variations Homozygous for AR p.Thr878Ala (c.2632A>G) (from parent cell line).
Heterozygous for MEN1 p.Tyr313Ter (c.939T>A) (from parent cell line).
Heterozygous for PIK3R1 p.Arg639Ter (c.1915C>T) (from parent cell line).
PTEN p.Lys6Argfs*4 (c.17_18delAA) (from parent cell line).
Disease Prostate carcinoma (NCIt: C4863)
Derived from metastatic site: Left supraclavicular lymph node.
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Parent: CVCL_0395 (LNCaP)
Sex of cell Male
Age at sampling 50Y
Category Cancer cell line
Web pages https://web.archive.org/web/20160322000315/http://capcelllines.ca/details.asp?id=175
Publications

PubMed=11861374
Zegarra-Moro O.L., Schmidt L.J., Huang H., Tindall D.J.
Disruption of androgen receptor function inhibits proliferation of androgen-refractory prostate cancer cells.
Cancer Res. 62:1008-1013(2002)

Cross-references
Other Wikidata; Q54902853
Entry history
Entry creation04-Apr-2012
Last entry update02-Jul-2020
Version number12